0 Canadian Stock Exchange News - September 16, 2024Green Thumb Industries Announces $50 Million Share Repurchase ProgramCHICAGO and VANCOUVER, British Columbia, Sept. 16, 2024 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (“Green Thumb” or the “Company”) […]Read More
0 Canadian Stock Exchange News - September 16, 2024Hemlo Explorers Provides Update on Pic Project OptionTORONTO, Sept. 16, 2024 (GLOBE NEWSWIRE) — Hemlo Explorers Inc. (the “Company”) (CSE: HMLO) is pleased to update its shareholders […]Read More
0 TSX News - September 16, 2024Stingray Brings Karaoke Fun to NIO Vehicles Across EuropeMONTREAL, Sept. 16, 2024 (GLOBE NEWSWIRE) — Stingray (TSX: RAY.A; RAY.B), a leader in music, video content distribution, business services, […]Read More
0 NYSE Companies - September 16, 2024Wabash Honored as One of America’s Most Admired Workplaces 2025 by NewsweekLAFAYETTE, Ind., Sept. 16, 2024 (GLOBE NEWSWIRE) — Wabash (NYSE: WNC), the visionary leader of connected solutions for the transportation, […]Read More
0 NYSE Companies - September 16, 2024Reliance, Inc. Announces Amended and Restated $1.5 Billion Credit FacilitySCOTTSDALE, Ariz., Sept. 16, 2024 (GLOBE NEWSWIRE) — Reliance, Inc. (NYSE: RS) announced today that effective September 10, 2024, it […]Read More
0 Canadian Stock Exchange News - September 16, 2024ThreeD Capital Inc. Announces Its Intention To Effect A Normal Course Issuer BidTORONTO, Sept. 16, 2024 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture […]Read More
0 NASDAQ Companies - September 16, 2024Haleon Selects PubMatic as Supply Optimisation Partner to Enable More Effective, Sustainable Media BuyingLONDON, Sept. 16, 2024 (GLOBE NEWSWIRE) — PubMatic (NASDAQ:PUBM), an independent technology company delivering digital advertising’s supply chain of the […]Read More
0 NASDAQ Companies - September 16, 2024Adagene Presents Results at ESMO Congress that Show Best-in-Class Therapeutic Potential for Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) in Combination with KEYTRUDA® (Pembrolizumab) in Advanced/Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)– Confirmed partial responses (PRs) doubled to four since ASCO GI in MSS CRC patients without liver and peritoneal metastases […]Read More